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To our knowledge, previous population-based surveys
have not assessed misconceptions about antibacterial drug
use over time. We documented a 26.3% decline in a key
misconception in California women in 2003 compared to
2000; declines varied significantly by education level.
Educational campaigns specifically designed to influence
important subpopulations are needed.
A
ntibacterial drug–resistant bacteria pose a substantial
challenge to public health. Inappropriate use of anti-
bacterial drugs, such as using them to treat viral respirato-
ry infections, accelerates the emergence of resistant
organisms (1,2). Nonclinical factors, such as patient
expectation and demand, contribute to inappropriate anti-
bacterial prescribing (3–6). To address patient misconcep-
tions and physician prescribing behavior, the Centers for
Disease Control and Prevention, along with states and pri-
vate health organizations, initiated educational programs
and campaigns to encourage the judicious use of antimi-
crobial drugs (7). In 1999, the California Medical
Association Foundation initiated the Alliance Working for
Antibiotic Resistance Education (AWARE) project.
AWARE, a coalition of public and private organizations,
was launched to educate physicians and consumers about
appropriate antibacterial drug use. In 2003, AWARE
worked with a coalition of minority physicians, including
Asian physicians, to reduce inappropriate antibacterial use
in minority communities (Elissa Maas, pers. comm.).
To date, few studies assess the effect of these educa-
tional campaigns over time, especially among underserved
populations. We surveyed a population-based sample of
California women to identify the magnitude of and charac-
teristics independently associated with the misconception
that a cold or flu should usually be treated with an antibac-
terial drug in 2000 and 2003. We assessed temporal trends
in the prevalence of this misconception by comparing the
prevalence reported in 2003 with that reported in 2000 for
the entire study sample and by specific risk characteristics.
The Study
The California Women’s Health Survey is an ongoing,
monthly telephone survey that collects information on
health-related behavior and attitudes from randomly
selected adult women (8,9). Trained staff interviewed par-
ticipants in 2000 (n = 4,012) and 2003 (n = 4,004) in
English (n = 7,058) or Spanish (n = 958). Participants
reported race, ethnicity, country of birth, year of entrance
into the United States, and current age, county of resi-
dence, number and age(s) of children, educational attain-
ment, household income, and access to healthcare
coverage. We defined the key misconception as an affirma-
tive answer to the following dichotomized question:
“Antibiotics, such as penicillin, doxycycline, or amoxi-
cillin, are used to treat a variety of medical conditions; do
you believe that a cold or flu should usually be treated with
antibiotics?”
We calculated the crude proportion of women who held
this misconception by year with weighted proportions and
Mantel-Haenszel chi-square statistics that adjusted each
sample to the age and race distribution of the 1990
California population (8,9). We examined the relationship
between the misconception and the characteristics listed in
Table 1 by year of study by using prevalence proportions
and unconditional logistic regression. To produce compa-
rable results, multivariate models for 2000 and 2003
included all variables that demonstrated a significant asso-
ciation with the misconception in either year in univariate
analyses. We developed a third multivariate model that
combined data from both years to assess the independent
association between the misconception and year of study.
While we used logistic regression to assess for confound-
ing, we present unadjusted prevalence ratios and calculate
relative prevalence reductions to measure changes in the
misconception over time. We did so because the unadjust-
ed and adjusted results by logistic regression were equiva-
lent (which suggests an absence of confounding) and
because the odds ratio did not reasonably approximate the
prevalence ratio for women without a high school educa-
tion (10). We considered p values <0.01 to be significant,
but we present 95% confidence intervals (CIs) to facilitate
comparing our results to those from other studies. We
restricted all models to participants who gave usable
responses to all variables (n = 7,430) and assessed models
for potential 2-way interactions, goodness of fit, and
potential colinearity.
In California, 21.0% of women surveyed in 2003
believed a cold or flu should usually be treated with an
antibacterial drug. Table 1 lists factors independently asso-
ciated with this key misconception among California
women. In both 2000 and 2003, the unadjusted prevalence
of the misconception was greatest among women who
were Hispanic, 18–34 years of age, had an annual house-
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resided in central or southern California, had lived in the
United States for <5 years, had children <6 years of age in
the household, or had no access to a healthcare plan.
We observed a 26.3% decline in the prevalence of the
misconception in all women surveyed in 2003 compared
with those surveyed in 2000 (21.0% vs. 28.5%, p<0.001).
Table 1 shows consistent declines across risk characteris-
tics, with several notable exceptions. First, we detected a
strong statistical interaction between education and year (p
= 0.007); women with a college diploma were 47.0% less
likely and women without a high school diploma were
17.0% less likely to report the misconception in 2003 than
those surveyed in 2000 (Table 2). Women with a high
school diploma were as likely to report the misconception
in 2000 and 2003. Second, although not significant, after
adjusting for other associated factors, Asian women were
55.7% less likely to report the misconception in 2003 com-
pared with those surveyed in 2000. Other women were, on
average, 24.0% less likely to report the misconception in
2003 than in 2000. Among women >55 years of age,
African American women were as likely to report the mis-
conception in 2003 as 2000, and their adjusted odds ratio
for the misconception increased from 3.1 (95% CI
1.70–5.67) in 2000 to 5.3 (95% CI 2.67–10.52) in 2003
(detailed data on race stratified by age and year not
shown).
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Our survey results show a 26.3% decline from 2000 to
2003 in the misconception among California women that a
cold or flu should usually be treated with an antibacterial
drug. This finding suggests that general educational cam-
paigns before and during this period may have contributed
to moderate reductions in the prevalence of misconcep-
tions about antibacterial drug use. Although this study was
not designed to evaluate specific interventions, our study
period and population-based sample can provide an eco-
logic assessment of changing beliefs. 
The decline in the misconception was greatest among
women who were non-Hispanic white or Asian, had at
least some college education, or had higher household
incomes. Among levels of education, why women who
graduated from high school had the smallest decline is
unclear. This finding may reflect a true unexplained find-
ing, an artifact of the sample (selection or information
bias), or chance. The inverse relationship between the mis-
conception and the presence of children <6 years of age in
the household in 2000 may indicate success in initial edu-
cational campaigns focused on pediatricians and mothers
with young children; that this relationship becomes less
significant in 2003 may indicate that other women are
“catching up.”
Our findings, drawn from a large, ethnically diverse,
population-based sample, show that 21.0% of California
women in 2003 still held the misconception, particularly
women who were younger, black, or Hispanic; had lower
educational attainment or household income; resided in
central and southern California; or had no healthcare cov-
erage. Although not restricted to women, other studies
identified similar demographic and socioeconomic risk
groups (11,12). Social services intended to reach persons
with these characteristics may be important venues for
education on appropriate antibacterial drug use.
Cultural and social perspectives of disease, including
differences in antibacterial drug regulations that affect the
availability and cost of drugs in immigrants’ countries of
birth, can play an important role in misconceptions about
antibacterial drugs (13,14). We documented racial and eth-
nic variation in California women with the misconception,
despite adjusting for selected socioeconomic factors; the
remaining variation likely reflects unmeasured socioeco-
nomic or cultural factors. We note, in particular, the per-
sistent prevalence of the misconception in African
American women and the decreased prevalence of it in
Asian women. While this study could not evaluate specif-
ic interventions, some California AWARE activities were
focused on Asian physicians during 2003. Other research
has documented racial and ethnic variation in parental
expectations of antibacterial drugs (15). New intervention
studies and campaigns aimed at educating and influencing
women in specific minority, education, and income sub-
groups about appropriate antibacterial drug use are needed.
Our study has several limitations. First, although
women may be more likely to be the health decisionmak-
ers for young children and for the household, we do not
know if our results can be generalized to men. Second, we
did not have sufficient sample size to explore specific sub-
groups within the Asian race category. Third, we only
included women in households with telephones who spoke
either Spanish or English and chose to participate. Fourth,
we were only able to interview women in Spanish or
English, which may limit comparability between immi-
grant Hispanic and Asian women. Finally, this misconcep-
tion may not equivocate to antibacterial drug expectation
or demand.
In conclusion, our surveys document a decline in a key
misconception in California women about appropriate anti-
bacterial drug use and support continuation of educational
campaigns to address this public health problem. Further
refining and focusing of these educational efforts are need-
ed to reach minority women and women with lower educa-
tional attainment and lower household incomes.
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